Kodiak Sciences (KOD) Cash from Operations (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Cash from Operations came in at 40009000.0 in Q1 2026, down 37.6% YoY from 64113623.2 in Q1 2025, and down 1.6% on a QoQ basis from 39378000.0 in Q4 2025.
Powered by 
Analysis
Kodiak Sciences (KOD) Cash from Operations (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Cash from Operations data on file, last reported at 40009000.0 in Q1 2026.
- Quarterly Cash from Operations fell 37.6% year-over-year to 40009000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 146940000.0 (down 37.61% YoY) and the FY2025 annual result came in at 136008000.0, down 15.95% from the prior year.
- Cash from Operations slipped to 40009000.0 in Q1 2026, from 39378000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 21149000.0 in Q3 2024 to a low of 55137000.0 in Q2 2022.
- A 5-year average of 38470588.24 and a median of 39378000.0 in 2025 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 41.51% — and 2025, when it tumbled 55.23%.
- Tracing KOD's Cash from Operations over 5 years: stood at 55116000.0 in 2022, then jumped by 41.51% to 32239000.0 in 2023, then increased by 6.79% to 30051000.0 in 2024, then sank by 31.04% to 39378000.0 in 2025, then fell by 1.6% to 40009000.0 in 2026.
- The last three Cash from Operations figures came in at 40009000.0 (Q1 2026), 39378000.0 (Q4 2025), and 32830000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - | -46.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.24 Mn |
| Mar 31, 2026 | -40.01 Mn |
| Dec 31, 2025 | -39.38 Mn |
| Sep 30, 2025 | -32.83 Mn |
| Jun 30, 2025 | -34.70 Mn |
| Mar 31, 2025 | -29.10 Mn |
| Dec 31, 2024 | -30.07 Mn |
| Sep 30, 2024 | -21.15 Mn |
| Jun 30, 2024 | -26.50 Mn |
| Mar 31, 2024 | -39.60 Mn |
| Dec 31, 2023 | -32.26 Mn |
| Sep 30, 2023 | -32.76 Mn |
| Jun 30, 2023 | -41.96 Mn |
| Mar 31, 2023 | -47.22 Mn |
| Dec 31, 2022 | -55.12 Mn |
| Sep 30, 2022 | -53.09 Mn |
| Jun 30, 2022 | -55.14 Mn |
| Mar 31, 2022 | -43.16 Mn |
| Dec 31, 2021 | -59.04 Mn |
| Sep 30, 2021 | -51.95 Mn |